#news #biotech GlaxoSmithKline culls early-stage Immunocore med as well as DMD asset in Q1 clear-out

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: GlaxoSmithKline culls early-stage Immunocore med as well as DMD asset in Q1 clear-out .GlaxoSmithKline culls early-stage Immunocore med as well as DMD asset in Q1 clear-out
badams
Wed, 04/28/2021 – 07:31

from FierceBiotech: Biotech https://ift.tt/3nv9lQB